These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 25282505)

  • 1. A semisynthetic carbohydrate-lipid vaccine that protects against S. pneumoniae in mice.
    Cavallari M; Stallforth P; Kalinichenko A; Rathwell DC; Gronewold TM; Adibekian A; Mori L; Landmann R; Seeberger PH; De Libero G
    Nat Chem Biol; 2014 Nov; 10(11):950-6. PubMed ID: 25282505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular helper NKT cells induce limited B cell responses and germinal center formation in the absence of CD4(+) T cell help.
    Tonti E; Fedeli M; Napolitano A; Iannacone M; von Andrian UH; Guidotti LG; Abrignani S; Casorati G; Dellabona P
    J Immunol; 2012 Apr; 188(7):3217-22. PubMed ID: 22379027
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Semisynthetic glycoconjugate based on dual role protein/PsaA as a pneumococcal vaccine.
    Prasanna M; Soulard D; Camberlein E; Ruffier N; Lambert A; Trottein F; Csaba N; Grandjean C
    Eur J Pharm Sci; 2019 Mar; 129():31-41. PubMed ID: 30572107
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycolipid-Containing Nanoparticle Vaccine Engages Invariant NKT Cells to Enhance Humoral Protection against Systemic Bacterial Infection but Abrogates T-Independent Vaccine Responses.
    Shute T; Amiel E; Alam N; Yates JL; Mohrs K; Dudley E; Salas B; Mesa C; Serrata A; Angel D; Vincent BK; Weyers A; Lanthier PA; Vomhof-Dekrey E; Fromme R; Laughlin M; Durham O; Miao J; Shipp D; Linhardt RJ; Nash K; Leadbetter EA
    J Immunol; 2021 Apr; 206(8):1806-1816. PubMed ID: 33811104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugation of polysaccharide 6B from Streptococcus pneumoniae with pneumococcal surface protein A: PspA conformation and its effect on the immune response.
    Perciani CT; Barazzone GC; Goulart C; Carvalho E; Cabrera-Crespo J; Gonçalves VM; Leite LC; Tanizaki MM
    Clin Vaccine Immunol; 2013 Jun; 20(6):858-66. PubMed ID: 23554468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human monoclonal antibodies isolated from a primary pneumococcal conjugate Vaccinee demonstrates the expansion of an antigen-driven Hypermutated memory B cell response.
    Chen Z; Cox KS; Tang A; Roman J; Fink M; Kaufhold RM; Guan L; Xie A; Boddicker MA; Mcguinness D; Xiao X; Li H; Skinner JM; Verch T; Retzlaff M; Vora KA
    BMC Infect Dis; 2018 Dec; 18(1):613. PubMed ID: 30509199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intranasal Immunization with the Commensal
    Shekhar S; Khan R; Schenck K; Petersen FC
    Appl Environ Microbiol; 2019 Mar; 85(6):. PubMed ID: 30683742
    [No Abstract]   [Full Text] [Related]  

  • 8. Pertussis toxin improves immune responses to a combined pneumococcal antigen and leads to enhanced protection against Streptococcus pneumoniae.
    Salcedo-Rivillas C; Debrie AS; Miyaji EN; Ferreira JM; Raw I; Locht C; Ho PL; Mielcarek N; Oliveira ML
    Clin Vaccine Immunol; 2014 Jul; 21(7):972-81. PubMed ID: 24807055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A semisynthetic
    Schumann B; Hahm HS; Parameswarappa SG; Reppe K; Wahlbrink A; Govindan S; Kaplonek P; Pirofski LA; Witzenrath M; Anish C; Pereira CL; Seeberger PH
    Sci Transl Med; 2017 Mar; 9(380):. PubMed ID: 28275152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with pneumococcal surface protein A in the presence of nanoparticle forming polysorbitol transporter adjuvant induces protective immunity against the Streptococcus pneumoniae infection.
    Kye YC; Park SM; Shim BS; Firdous J; Kim G; Kim HW; Ju YJ; Kim CG; Cho CS; Kim DW; Cho JH; Song MK; Han SH; Yun CH
    Acta Biomater; 2019 May; 90():362-372. PubMed ID: 30922953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against fatal pneumonia through mucosal and subcutaneous immunization with the pneumococcal SP0148 protein.
    Huang J; Luo S; Huang M; Zhang T; Min Z; Liu C; Zhang Q; Yang J; Min X
    Microb Pathog; 2019 Apr; 129():206-212. PubMed ID: 30772476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production and efficacy of a low-cost recombinant pneumococcal protein polysaccharide conjugate vaccine.
    Herbert JA; Kay EJ; Faustini SE; Richter A; Abouelhadid S; Cuccui J; Wren B; Mitchell TJ
    Vaccine; 2018 Jun; 36(26):3809-3819. PubMed ID: 29778517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a conjugate vaccine against invasive pneumococcal disease based on capsular polysaccharides coupled with PspA/family 1 protein of Streptococcus pneumoniae.
    Lin H; Peng Y; Lin Z; Zhang S; Guo Y
    Microb Pathog; 2015; 83-84():35-40. PubMed ID: 25959527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trivalent pneumococcal protein vaccine protects against experimental acute otitis media caused by Streptococcus pneumoniae in an infant murine model.
    Xu Q; Pryharski K; Pichichero ME
    Vaccine; 2017 Jan; 35(2):337-344. PubMed ID: 27919628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal immunization with an unadjuvanted vaccine that targets Streptococcus pneumoniae PspA to human Fcγ receptor type I protects against pneumococcal infection through complement- and lactoferrin-mediated bactericidal activity.
    Bitsaktsis C; Iglesias BV; Li Y; Colino J; Snapper CM; Hollingshead SK; Pham G; Gosselin DR; Gosselin EJ
    Infect Immun; 2012 Mar; 80(3):1166-80. PubMed ID: 22158740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killer T (NKT)-B-cell interactions promote prolonged antibody responses and long-term memory to pneumococcal capsular polysaccharides.
    Bai L; Deng S; Reboulet R; Mathew R; Teyton L; Savage PB; Bendelac A
    Proc Natl Acad Sci U S A; 2013 Oct; 110(40):16097-102. PubMed ID: 24043771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunization with components of two iron uptake ABC transporters protects mice against systemic Streptococcus pneumoniae infection.
    Brown JS; Ogunniyi AD; Woodrow MC; Holden DW; Paton JC
    Infect Immun; 2001 Nov; 69(11):6702-6. PubMed ID: 11598041
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptide-free Synthetic Nicotine Vaccine Candidates with α-Galactosylceramide as Adjuvant.
    Chen XZ; Zhang RY; Wang XF; Yin XG; Wang J; Wang YC; Liu X; Du JJ; Liu Z; Guo J
    Mol Pharm; 2019 Apr; 16(4):1467-1476. PubMed ID: 30821985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and delivery of
    Su H; Liu Q; Bian X; Wang S; Curtiss R; Kong Q
    Proc Natl Acad Sci U S A; 2021 Jan; 118(2):. PubMed ID: 33380455
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease.
    Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y
    Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.